STOCK TITAN

[8-K] Nucor Corporation Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Broadridge Financial Solutions (BR) – Form 4/A insider filing

Director Robert N. Duelks submitted an amended Form 4 detailing a 06/06/2025 transaction. The amendment corrects the original filing to show that the Robert N. Duelks 2007 Revocable Trust—not the director’s direct account—sold 500 common shares at $245.1495 (code “S”).

Post-sale holdings stand at 8,853 BR shares for the trust (indirect ownership “I”) and 20,358 shares held directly by Duelks. No derivative securities or additional transactions were reported.

The update improves disclosure accuracy but also confirms a modest insider sale.

Broadridge Financial Solutions (BR) – Comunicazione interna Modulo 4/A

Il direttore Robert N. Duelks ha presentato un Modulo 4 modificato riguardante una transazione del 06/06/2025. La modifica corregge la dichiarazione originale, specificando che è stato il Robert N. Duelks 2007 Revocable Trust—e non il conto diretto del direttore—a vendere 500 azioni ordinarie a 245,1495 dollari (codice “S”).

Dopo la vendita, il trust detiene 8.853 azioni BR (proprietà indiretta “I”) mentre Duelks possiede direttamente 20.358 azioni. Non sono stati segnalati titoli derivati o altre transazioni.

L’aggiornamento migliora la precisione delle informazioni divulgate e conferma una vendita interna modesta.

Broadridge Financial Solutions (BR) – Presentación interna Formulario 4/A

El director Robert N. Duelks presentó un Formulario 4 enmendado detallando una transacción del 06/06/2025. La enmienda corrige la presentación original para mostrar que el Robert N. Duelks 2007 Revocable Trust, y no la cuenta directa del director, vendió 500 acciones ordinarias a 245,1495 dólares (código “S”).

Tras la venta, el fideicomiso posee 8.853 acciones de BR (propiedad indirecta “I”) y Duelks mantiene 20.358 acciones en propiedad directa. No se reportaron valores derivados ni transacciones adicionales.

La actualización mejora la precisión de la divulgación y confirma una venta interna modesta.

Broadridge Financial Solutions (BR) – 내부자 신고서 Form 4/A 수정 제출

이사 Robert N. Duelks가 2025년 6월 6일 거래 내역을 상세히 기재한 수정된 Form 4를 제출했습니다. 수정 내용은 원래 제출서에서 이사 본인의 직접 계좌가 아닌 Robert N. Duelks 2007 Revocable Trust가 500주를 주당 245.1495달러에 매도했음을 반영합니다(코드 “S”).

매도 후 해당 신탁은 BR 주식 8,853주(간접 소유 “I”)를 보유하며, Duelks 본인은 직접 20,358주를 보유하고 있습니다. 파생 증권이나 추가 거래는 보고되지 않았습니다.

이번 업데이트는 공시 정확성을 높이며 소규모 내부자 매도를 확인합니다.

Broadridge Financial Solutions (BR) – Déclaration d’initié Formulaire 4/A

Le directeur Robert N. Duelks a soumis un Formulaire 4 modifié détaillant une transaction du 06/06/2025. La modification rectifie la déclaration initiale en précisant que c’est le Robert N. Duelks 2007 Revocable Trust—et non le compte direct du directeur—qui a vendu 500 actions ordinaires au prix de 245,1495 $ (code « S »).

Après la vente, le trust détient 8 853 actions BR (propriété indirecte « I ») et Duelks en possède directement 20 358. Aucun titre dérivé ni transaction supplémentaire n’a été signalé.

Cette mise à jour améliore la précision de la divulgation et confirme une vente interne modérée.

Broadridge Financial Solutions (BR) – Insider-Meldung Formular 4/A

Direktor Robert N. Duelks reichte ein geändertes Formular 4 ein, das eine Transaktion vom 06.06.2025 beschreibt. Die Änderung korrigiert die ursprüngliche Meldung und zeigt, dass der Robert N. Duelks 2007 Revocable Trust – und nicht das direkte Konto des Direktors – 500 Stammaktien zu 245,1495 USD (Code „S“) verkauft hat.

Nach dem Verkauf hält der Trust 8.853 BR-Aktien (indirekter Besitz „I“) und Duelks selbst 20.358 Aktien direkt. Es wurden keine Derivate oder weitere Transaktionen gemeldet.

Das Update verbessert die Genauigkeit der Offenlegung und bestätigt einen moderaten Insider-Verkauf.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small trust sale; corrective filing; immaterial to BR valuation—neutral impact.

The transaction involves only 500 shares, a negligible portion of Broadridge’s float and of Duelks’ combined 29,211-share stake. Because the stock was sold by a revocable trust, it likely reflects personal portfolio management rather than a signal on fundamentals. The amendment removes a classification error, restoring clarity to insider ownership data. No change to earnings outlook, liquidity, or capital structure; therefore I view the market impact as neutral.

TL;DR: Filing corrects ownership misstatement; transparency improved, but initial error is a governance blemish.

Section 16 compliance requires precise disclosure. The original misclassification—direct versus indirect holding—was promptly fixed, limiting regulatory risk. While the 500-share sale is minor, the need for an amendment highlights the importance of robust internal controls over insider reporting. Investors should monitor for repeat errors, yet one isolated correction is unlikely to sway governance assessments materially.

Broadridge Financial Solutions (BR) – Comunicazione interna Modulo 4/A

Il direttore Robert N. Duelks ha presentato un Modulo 4 modificato riguardante una transazione del 06/06/2025. La modifica corregge la dichiarazione originale, specificando che è stato il Robert N. Duelks 2007 Revocable Trust—e non il conto diretto del direttore—a vendere 500 azioni ordinarie a 245,1495 dollari (codice “S”).

Dopo la vendita, il trust detiene 8.853 azioni BR (proprietà indiretta “I”) mentre Duelks possiede direttamente 20.358 azioni. Non sono stati segnalati titoli derivati o altre transazioni.

L’aggiornamento migliora la precisione delle informazioni divulgate e conferma una vendita interna modesta.

Broadridge Financial Solutions (BR) – Presentación interna Formulario 4/A

El director Robert N. Duelks presentó un Formulario 4 enmendado detallando una transacción del 06/06/2025. La enmienda corrige la presentación original para mostrar que el Robert N. Duelks 2007 Revocable Trust, y no la cuenta directa del director, vendió 500 acciones ordinarias a 245,1495 dólares (código “S”).

Tras la venta, el fideicomiso posee 8.853 acciones de BR (propiedad indirecta “I”) y Duelks mantiene 20.358 acciones en propiedad directa. No se reportaron valores derivados ni transacciones adicionales.

La actualización mejora la precisión de la divulgación y confirma una venta interna modesta.

Broadridge Financial Solutions (BR) – 내부자 신고서 Form 4/A 수정 제출

이사 Robert N. Duelks가 2025년 6월 6일 거래 내역을 상세히 기재한 수정된 Form 4를 제출했습니다. 수정 내용은 원래 제출서에서 이사 본인의 직접 계좌가 아닌 Robert N. Duelks 2007 Revocable Trust가 500주를 주당 245.1495달러에 매도했음을 반영합니다(코드 “S”).

매도 후 해당 신탁은 BR 주식 8,853주(간접 소유 “I”)를 보유하며, Duelks 본인은 직접 20,358주를 보유하고 있습니다. 파생 증권이나 추가 거래는 보고되지 않았습니다.

이번 업데이트는 공시 정확성을 높이며 소규모 내부자 매도를 확인합니다.

Broadridge Financial Solutions (BR) – Déclaration d’initié Formulaire 4/A

Le directeur Robert N. Duelks a soumis un Formulaire 4 modifié détaillant une transaction du 06/06/2025. La modification rectifie la déclaration initiale en précisant que c’est le Robert N. Duelks 2007 Revocable Trust—et non le compte direct du directeur—qui a vendu 500 actions ordinaires au prix de 245,1495 $ (code « S »).

Après la vente, le trust détient 8 853 actions BR (propriété indirecte « I ») et Duelks en possède directement 20 358. Aucun titre dérivé ni transaction supplémentaire n’a été signalé.

Cette mise à jour améliore la précision de la divulgation et confirme une vente interne modérée.

Broadridge Financial Solutions (BR) – Insider-Meldung Formular 4/A

Direktor Robert N. Duelks reichte ein geändertes Formular 4 ein, das eine Transaktion vom 06.06.2025 beschreibt. Die Änderung korrigiert die ursprüngliche Meldung und zeigt, dass der Robert N. Duelks 2007 Revocable Trust – und nicht das direkte Konto des Direktors – 500 Stammaktien zu 245,1495 USD (Code „S“) verkauft hat.

Nach dem Verkauf hält der Trust 8.853 BR-Aktien (indirekter Besitz „I“) und Duelks selbst 20.358 Aktien direkt. Es wurden keine Derivate oder weitere Transaktionen gemeldet.

Das Update verbessert die Genauigkeit der Offenlegung und bestätigt einen moderaten Insider-Verkauf.

NUCOR CORP false 0000073309 0000073309 2025-07-28 2025-07-28
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 28, 2025

 

 

NUCOR CORPORATION

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   1-4119   13-1860817

(State or Other Jurisdiction

of Incorporation)

  (Commission
File Number)
 

(IRS Employer

Identification No.)

1915 Rexford Road,

Charlotte, NC

    28211
(Address of Principal Executive Offices)     (Zip Code)

Registrant’s Telephone Number, Including Area Code: (704) 366-7000

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common Stock, par value $0.40 per share   NUE   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 2.02.

Results of Operations and Financial Condition.

On July 28, 2025, Nucor Corporation issued a news release reporting its financial results for the quarter ended July 5, 2025. A copy of the news release is furnished as Exhibit 99.1 and incorporated herein by reference.

 

Item 7.01.

Regulation FD Disclosure.

On July 28, 2025, Nucor Corporation, in conjunction with the issuance of the aforementioned news release, posted an investor presentation to its Investor Relations website. A copy of the investor presentation is furnished as Exhibit 99.2 and incorporated herein by reference.

 

Item 9.01.

Financial Statements and Exhibits.

 

  (d)

Exhibits

 

99.1    News Release of Nucor Corporation dated July 28, 2025
99.2    Investor Presentation dated July 28, 2025
104    Cover Page from this Current Report on Form 8-K, formatted in Inline XBRL

The information contained in this Current Report on Form 8-K, including the exhibits attached hereto, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. Furthermore, the information contained in this Current Report on Form 8-K shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such registration statement or other document.

 

1


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NUCOR CORPORATION
Date: July 28, 2025     By:  

/s/ Stephen D. Laxton

      Stephen D. Laxton
     

Chief Financial Officer and Executive

Vice President

 

2

FAQ

How many Broadridge (BR) shares did Robert Duelks' trust sell on 06/06/2025?

The Form 4/A reports a sale of 500 common shares by the Robert N. Duelks 2007 Revocable Trust.

At what price were the Broadridge shares sold?

The shares were sold at $245.1495 per share.

How many BR shares does the trust own after the sale?

Following the transaction, the trust owns 8,853 shares indirectly.

Why was the Form 4 amended?

The amendment corrects the earlier filing, showing the sale came from the revocable trust rather than Duelks’ direct holdings.

What are Robert Duelks’ direct holdings in Broadridge after the amendment?

He continues to hold 20,358 shares directly, unchanged by this filing.
Nucor

NYSE:NUE

NUE Rankings

NUE Latest News

NUE Latest SEC Filings

NUE Stock Data

33.65B
229.09M
0.53%
79.81%
1.92%
Steel
Steel Works, Blast Furnaces & Rolling Mills (coke Ovens)
Link
United States
CHARLOTTE